Cargando…
AB093. The efficacy of medical treatment of Peyronie’s disease: Potaba monotherapy vs. combination therapy with Tamoxifen, L-carnitine, and PDE5 inhibitor
OBJECTIVE: This study was designed to evaluate the efficacy of combination therapy of Tamoxifen, L-carnitine and daily PDE5 inhibitors and to compare with Potassium para-aminobenzoate (Potaba) monotherapy in the medical treatment of Peyronie’s disease. METHODS: From January 2011 to December 2014, a...
Autores principales: | Park, Jong Jin, Kim, Jong Wook, Moon, Du Geon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842572/ http://dx.doi.org/10.21037/tau.2016.s093 |
Ejemplares similares
-
AB081. Effects of combination therapy of Tamoxifen, L-carnitine and daily PDE5 inhibitors in the Peyronie’s disease
por: Kang, Jae Il, et al.
Publicado: (2016) -
The Efficacy of Medical Treatment of Peyronie's Disease: Potassium Para-Aminobenzoate Monotherapy vs. Combination Therapy with Tamoxifen, L-Carnitine, and Phosphodiesterase Type 5 Inhibitor
por: Park, Tae Yong, et al.
Publicado: (2016) -
AB082. The outcome of multiple slit on plaque with plication technique for the treatment of Peyronie’s disease
por: Kang, Jae Il, et al.
Publicado: (2016) -
AB146. National sex survey in South Korea
por: Moon, Du Geon, et al.
Publicado: (2015) -
AB041. Evolution of PDE5 inhibitors in Korea
por: Moon, Du Geon
Publicado: (2015)